Colgate-Palmolive reported Q3 2025 Net Sales of $5,131M (up 2.0% YoY, 0.4% organic growth), with Diluted EPS rising to $0.91 from $0.90. Nine-Month YTD Net Sales were flat at $15,152M, though Diluted EPS grew to $2.67. Gross Margin compressed to 59.4% due to 600 bps higher raw material costs. Net Income attributable for 9 months was $2,169M, significantly benefiting from a favorable $329M Cumulative Translation Adjustment within Other Comprehensive Income (OCI).
The Balance Sheet saw Total Assets grow to $17.5B and Total Equity more than double to $1.238B, supported by growth in Reta
...